Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors.

MLA

Gubbi, Sriram, et al. “Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors.” Hormone & Metabolic Research, vol. 54, no. 12, Dec. 2022, pp. 795–812. EBSCOhost, https://doi.org/10.1055/a-1908-7790.

APA

Gubbi, S., Vijayvergia, N., Yu, J. Q., Klubo-Gwiezdzinska, J., & Koch, C. A. (2022). Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors. Hormone & Metabolic Research, 54(12), 795–812. https://doi.org/10.1055/a-1908-7790

Chicago

Gubbi, Sriram, Namrata Vijayvergia, Jian Q Yu, Joanna Klubo-Gwiezdzinska, and Christian A. Koch. 2022. “Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors.” Hormone & Metabolic Research 54 (12): 795–812. doi:10.1055/a-1908-7790.